Clinical Trial Update: Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating selective lymph node dissection guided by a fluorescent dye in patients with node-positive breast cancer. The trial status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: Breast Neoplasms | Phase 4 | Status: UNKNOWN